Since PGE2 can promote BC tumorigenesis, the study concluded that 15 d-PGJ2 may activate ELK1, but instead of attributing ELK1’d expression with tumorigenic activity, its activation may result in tumor-suppressive effects [93]. This evidence concerns the gene ELK1 and breast cancer.